• Point Icon Director of the Center for Colon and Rectal Surgery at McGill University Health Center.
  • Point Icon Assistant Professor of Surgery and Oncology at McGill University.
  • Point Icon Specializes in endoscopic management of polyps, surgical treatment of colon and rectal cancer, and inflammatory bowel disease.
  • Point Icon Utilizes laparoscopic techniques in his practice since 1992.
  • Point Icon Research focuses on multimodal management of rectal cancer, ERAS, Minimally Invasive Surgery, and Prehabilitation.
  • Point Icon Significant contributions to surgical education, including roles on the General Surgery Residency Training committee and as Assistant Program Director in General Surgery at McGill.
  • Point Icon Recipient of multiple teaching awards in the Department of Surgery at McGill.
  • Point Icon Completed medical degree, General Surgery training, and a GI fellowship at McGill University.
  • Point Icon Subspecialty training in Colon and Rectal Surgery at the Lahey Clinic, Boston.
  • Point Icon Worked at the Jewish General Hospital for 10 years before founding the Center for Colon and Rectal Surgery at McGill University Health Center in 2003.
  • Point Icon Co-founder of a prominent ambulatory endoscopy center in Westmount, Quebec for 16 years.
  • Point Icon Certified by the Royal College of Surgeons of Canada, American Board of Surgery, and American Board of Colon and Rectal Surgery.
  • Point Icon Fellow of the Royal College of Surgeons of Canada, the American College of Surgeons, and the American Board of Colon & Rectal Surgery.

Bio:

Barry L. Stein, MDCM, FRCPSC, FACS, FASCRS. Is the Director of the Center for Colon and Rectal Surgery at the McGill University Health Center (Royal Victoria Hospital and Montreal General Hospital) . He holds the rank of Assistant Professor of Surgery and Oncology at McGill University.

His specialty interests include the endoscopic management of polyps, surgical treatment of colon and rectal cancer and inflammatory bowel disease. His practice includes the extensive use of laparoscopic techniques to treat these surgical diseases since 1992. His research interests include the multimodal management of rectal cancer, preoperative radiotherapy for rectal cancer in a watchful waiting program, Enhanced Recovery After Surgery (ERAS), Minimally Invasive Surgery and Prehabilitation in the deconditioned patient.

He also has a special interest in surgical education and served on the General Surgery Residency Training committee for many years as well as served as the Assistant Program Director in General Surgery for many years. He has earned multiple teaching awards at McGill in the Department of Surgery.

Dr. Stein earned his medical degree at McGill University in Montreal and then completed his General Surgery training at McGill. He subsequently did a 1-year GI fellowship including endoscopy at McGill. After that he completed 2 years of subspecialty training in Colon and Rectal Surgery and Colonoscopy at the Lahey Clinic, Boston, Massachusetts. He returned to Montreal and worked at the Jewish General Hospital for 10 years before moving over to the McGill University Health Center and establishing the Center for Colon and Rectal Surgery where is has been the Director since 2003.

He was also one of the founders and managing partners of a large busy ambulatory endoscopy center for 16 years in Westmount, Quebec. He has extensive experience in performing anal surgery under local anesthesia.

He is certified by the Royal College of Surgeons of Canada in General Surgery, the American Board of Surgery, the American Board of Colon and Rectal Surgery and holds a specialist certificate in Colon and Rectal Surgery from the College des Medecins du Quebec.

Dr. Stein is a Fellow of the Royal College of Surgeons of Canada, the American College of Surgeons and the American Board of Colon & Rectal Surgery.

Research

In 2023, Dr. Stein BL authored a comprehensive article discussing the sequencing of treatment in myelofibrosis, especially in the context of the emerging era with multiple treatment options. This insightful piece was published in "Leuk Lymphoma." In another significant contribution in 2021, Dr. Stein BL delved into the management of anemia associated with myelofibrosis, emphasizing both standard agents and novel therapeutics currently in Phase 3 clinical trials. This research was featured in "Curr Hematol Malig Rep." Additionally, in collaboration with Galvez C in 2020, Dr. Stein BL explored the potential correlation between thrombocytosis and thrombosis, questioning the widely accepted association. This study was also published in "Curr Hematol Malig Rep."

Our Leading Surgeons

Publications

modal image
  • Stein BL. JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple options. Leuk Lymphoma. 2023 Feb;64(2):292-299. doi: 10.1080/10428194.2022.2136970. Epub 2022 Oct 27. PMID: 36301740.

  • Stein BL. Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical Trials. Curr Hematol Malig Rep. 2021 Oct;16(5):483-489. doi: 10.1007/s11899-021-00651-3. Epub 2021 Sep 9. PMID: 34499329.

  • Galvez C, Stein BL. Thrombocytosis and Thrombosis: Is There Really a Correlation? Curr Hematol Malig Rep. 2020 Aug;15(4):261-267. doi: 10.1007/s11899-020-00588-z. PMID: 32399765.